Enuresis, Encopresis & Tic Disorders
Psychiatry · Childhood · lean revision notes
Enuresis, Encopresis & Tic Disorders
A trio of childhood "elimination + movement" disorders that are favourites for one-liner NEET PG questions. The exam loves the cut-off ages (5 years for enuresis, 4 years for encopresis), the drug of choice (desmopressin/imipramine, alarm therapy), and Tourette's "multiple motor + at least one vocal tic for >1 year" criterion with haloperidol/risperidone management.
1. Elimination disorders — the framework
Elimination disorders cover enuresis (urine) and encopresis (faeces). Both require that the child has reached, or should have reached, the developmental age of bladder/bowel control, and that the problem is not better explained by a medical condition or substance.
High-yield: Always confirm the child has attained the chronological/developmental age of continence before labelling either disorder — 5 years for enuresis, 4 years for encopresis. Below these ages, the behaviour is developmentally normal.
| Feature | Enuresis | Encopresis |
|---|---|---|
| Substance | Urine | Faeces |
| Minimum age (DSM-5) | 5 years | 4 years |
| Frequency criterion | ≥2×/week for ≥3 months OR significant distress/impairment | ≥1 event/month for ≥3 months |
| Common subtype | Nocturnal (primary) | Retentive (with constipation/overflow) |
| Sex bias | Boys > girls (nocturnal) | Boys > girls |
| First-line therapy | Behavioural + alarm; desmopressin | Disimpaction + laxatives + toilet training |
2. Enuresis
Definition & classification
Enuresis = repeated voiding of urine into bed or clothes, voluntary or involuntary, in a child ≥5 years (or equivalent developmental level), not due to a substance (e.g., diuretic) or general medical condition (e.g., diabetes, spina bifida, seizure, UTI).
DSM-5 threshold: at least twice a week for ≥3 consecutive months, or marked distress/functional impairment.
Two clinically vital axes of classification:
- By timing
- Nocturnal — bedwetting only (most common; ~80%).
- Diurnal — daytime wetting only.
- Nocturnal + diurnal — mixed.
- By prior continence
- Primary — child has never achieved a sustained dry period (≥6 months). ~80% of cases. Strong genetic/maturational basis.
- Secondary — wetting recurs after ≥6 months of established dryness. More often linked to psychosocial stressors (new sibling, abuse, divorce, school stress) or a medical trigger (UTI, diabetes).
High-yield: Primary nocturnal enuresis is the single most common presentation and most often represents delayed maturation of bladder control + a positive family history, NOT a primary psychiatric illness.
Etiology & pathophysiology
The core mechanisms tested are:
- Genetic — concordance high; one parent affected → ~45% risk; both → ~75%. Linked loci on chromosomes 12, 13.
- Maturational delay of cortical inhibition of the micturition reflex / small functional bladder capacity.
- Nocturnal polyuria — blunted nocturnal rise in antidiuretic hormone (ADH/vasopressin) → high overnight urine volume exceeding bladder capacity. This is the rationale for desmopressin.
- High arousal threshold — failure to wake to a full bladder.
- Psychosocial stress — especially in secondary enuresis.
Approach to the bedwetting child:
Step 1 → rule out organic causes (urinalysis ± culture, blood glucose; exclude UTI, diabetes mellitus/insipidus, neurogenic bladder, posterior urethral valves, constipation) → Step 2 reassure & demystify (most resolve spontaneously, ~15% remission per year) → Step 3 behavioural measures (fluid restriction in evening, voiding before bed, motivational star charts) → Step 4 enuresis alarm (best long-term cure) → Step 5 pharmacotherapy (desmopressin / imipramine) for rapid or short-term control (e.g., camps, sleepovers).
Diagnosis & investigation of choice
- Diagnosis is clinical (history + age + frequency).
- Investigation of choice for initial screen: urinalysis (and urine culture if symptoms) to exclude UTI, glycosuria, and concentrating defects.
- Voiding diary / functional bladder capacity assessment for daytime or refractory cases.
- Ultrasound / urodynamics only if neurogenic or structural cause suspected.
Management / drug of choice
| Modality | Mechanism / role | Key exam points |
|---|---|---|
| Enuresis alarm | Moisture sensor → conditioning to wake/inhibit voiding | Best long-term cure, lowest relapse; needs motivated family, 3–4 months |
| Desmopressin | Synthetic ADH analogue ↓ nocturnal urine volume | Drug of choice (esp. nocturnal polyuria, short-term use); risk = hyponatraemia/water intoxication → restrict evening fluids |
| Imipramine | TCA; anticholinergic + ↑ bladder capacity + ↓ REM/arousal effect; ? mild ADH-like effect | Classic NEET answer for mechanism; danger = cardiotoxicity in overdose (arrhythmia), narrow therapeutic index |
| Oxybutinin / anticholinergics | ↓ detrusor overactivity | Useful in diurnal enuresis / overactive bladder |
High-yield: Behavioural therapy + enuresis alarm is first-line and gives the best long-term cure. Desmopressin is the pharmacological drug of choice (rapid, useful for sleepovers). Imipramine is reserved/second-line because of cardiotoxicity in overdose.
High-yield (most-tested mechanism): Imipramine in enuresis works through anticholinergic action increasing functional bladder capacity, effects on sleep architecture (decreasing arousal/REM), and a possible weak antidiuretic effect — this exact mechanism statement is a recurring single-best-answer.
Mnemonic — "ADAM" for enuresis treatment ladder: Alarm → Desmopressin → Anticholinergic (oxybutinin) → iMipramine.
3. Encopresis
Definition & classification
Encopresis = repeated passage of faeces into inappropriate places (clothing, floor), whether involuntary or intentional, in a child ≥4 years (or developmental equivalent), at least once a month for ≥3 months, not due solely to a substance or medical condition (other than constipation mechanisms).
Two subtypes (critical to distinguish):
| Type | Mechanism | Clinical picture |
|---|---|---|
| Retentive (with constipation & overflow incontinence) | Chronic constipation → faecal impaction → liquid stool leaks around the mass (paradoxical/overflow soiling) | ~80–90% of cases; palpable faecal mass, painful defecation, stool withholding |
| Non-retentive (functional, without constipation) | No constipation; soiling often related to oppositional behaviour, anxiety, poor toilet training, or psychological factors | Normal-consistency stool deposited in inappropriate places; stronger behavioural/psychiatric association |
High-yield: Most encopresis is the retentive (overflow) type secondary to chronic constipation — the leaking stool is paradoxically loose, which can fool you into thinking it is diarrhoea. The "diarrhoea" is overflow around an impaction.
Etiology & pathophysiology
- Retentive: painful/hard stool → voluntary withholding → rectal distension → stretched, hypotonic rectum with reduced sensation → impaction → liquid overflow. Reinforced by a vicious cycle of pain-avoidance.
- Non-retentive/functional: inadequate or coercive toilet training, oppositional defiant traits, stressors, sometimes regression after a stressor (secondary).
- Organic differentials to exclude: Hirschsprung disease, hypothyroidism, anal fissure, spinal dysraphism, cow's-milk protein intolerance.
High-yield: Hirschsprung disease is the key differential. Clues against simple encopresis and toward Hirschsprung: onset in neonatal period, delayed passage of meconium (>48 h), failure to thrive, empty rectum on PR with explosive stool, and an absent rectoanal inhibitory reflex on anorectal manometry. Confirm with rectal biopsy (absent ganglion cells).
Diagnosis & investigation
- Clinical diagnosis + careful history of bowel pattern, withholding posturing, diet.
- Abdominal examination / per-rectal exam → palpable faecal mass in retentive type.
- Plain abdominal X-ray → faecal loading/impaction (supports retentive type).
- Anorectal manometry + rectal biopsy only when Hirschsprung is suspected.
Management
Stepwise approach:
- Education & demystification — explain overflow mechanism, remove blame.
- Disimpaction — oral (PEG/polyethylene glycol — first choice) or enema for severe impaction.
- Maintenance laxatives — osmotic laxatives (PEG, lactulose) to keep stools soft for weeks–months.
- Behavioural toilet training — scheduled post-meal toilet sitting (exploit gastrocolic reflex), positive reinforcement/star charts.
- Dietary fibre + fluids.
- Treat the non-retentive/psychological component with behaviour therapy; address family conflict.
High-yield: In retentive encopresis, the sequence is DISIMPACTION first → then MAINTENANCE laxatives → then behavioural toilet training. Starting toilet training before clearing the impaction fails.
4. Tic Disorders & Tourette Syndrome
Definition & classification
A tic is a sudden, rapid, recurrent, non-rhythmic, stereotyped motor movement or vocalisation. Tics are suppressible (temporarily, with effort), suggestible, often preceded by an uncomfortable premonitory urge relieved by performing the tic, and wax and wane in severity. They typically worsen with stress/fatigue/excitement and may persist during sleep (unlike many other movement disorders).
- Simple motor tics: eye blinking, shoulder shrug, head jerk, facial grimace.
- Complex motor tics: jumping, touching, copropraxia (obscene gestures), echopraxia (imitating others' movements).
- Simple vocal tics: sniffing, throat clearing, grunting, coughing.
- Complex vocal tics: coprolalia (involuntary obscene words — present in only ~10–15%, NOT required for diagnosis), echolalia (repeating others' words), palilalia (repeating one's own words).
DSM-5 classification of tic disorders
| Disorder | Tic types | Duration | Onset |
|---|---|---|---|
| Tourette syndrome (TS) | Multiple motor tics AND ≥1 vocal tic (not necessarily concurrent) | >1 year | <18 years |
| Persistent (chronic) motor OR vocal tic disorder | Motor OR vocal (not both) | >1 year | <18 years |
| Provisional tic disorder | Single or multiple, motor and/or vocal | <1 year | <18 years |
High-yield (the classic stem): Tourette syndrome = multiple motor tics + at least one vocal tic, present for more than 1 year, with onset before age 18. Both motor and vocal tics need NOT occur at the same time. Coprolalia is NOT required for diagnosis.
Etiology & pathophysiology
- Genetic / familial — strong heritability.
- Dysregulation of cortico–striato–thalamo–cortical (CSTC) circuits with dopaminergic hyperactivity in the basal ganglia → rationale for dopamine antagonists.
- Onset typically 4–6 years, peak severity around 10–12 years, and improvement/remission in many by late adolescence/early adulthood.
- Possible post-streptococcal autoimmune contribution (PANDAS — controversial).
Comorbidities (heavily tested)
High-yield: Tourette syndrome is strongly comorbid with ADHD (most common) and OCD. Always screen for both — comorbidities often cause more impairment than the tics themselves.
Mnemonic — "TOAD" associations of Tourette: Tics, OCD, ADHD, Dopamine excess.
Management / drug of choice
Stepwise:
Mild/non-impairing tics → psychoeducation + reassurance + watchful waiting → behavioural therapy (CBIT — Comprehensive Behavioural Intervention for Tics / Habit Reversal Training) → pharmacotherapy only if tics are distressing/impairing.
| Drug class | Examples | Notes |
|---|---|---|
| Typical antipsychotics (D2 blockers) | Haloperidol, pimozide | Classic NEET answer; haloperidol is the historically "first approved" agent; pimozide → watch QT prolongation (ECG) |
| Atypical antipsychotics | Risperidone, aripiprazole | Increasingly preferred — better side-effect profile; aripiprazole now widely first-line pharmacological choice |
| Alpha-2 agonists | Clonidine, guanfacine | Good when tics + ADHD coexist; first-line for milder tics; fewer EPS |
High-yield: Haloperidol is the time-honoured/"classic" NEET answer as the drug of choice for Tourette syndrome; risperidone and aripiprazole are the modern preferred antipsychotics, and clonidine/guanfacine are favoured when ADHD coexists or when avoiding antipsychotic side effects.
High-yield: For Tourette + ADHD, alpha-2 agonists (clonidine/guanfacine) treat both. Stimulants for ADHD were traditionally said to worsen tics, but current evidence shows they can be used cautiously; alpha-2 agonists remain a safe combined option.
5. Key differentials (quick comparison)
| Presentation | Consider instead of... | Distinguishing clue |
|---|---|---|
| Bedwetting + polyuria + weight loss | Diabetes mellitus/insipidus | Glycosuria, hyperglycaemia, high output |
| Bedwetting + dysuria/frequency | UTI | Pyuria, positive culture |
| Soiling + neonatal constipation + empty rectum | Hirschsprung disease | Absent ganglion cells on biopsy, absent RAIR |
| Soiling + diarrhoea-like leak | Overflow (retentive encopresis) | Palpable faecal mass, X-ray loading |
| Stereotyped movements not suppressible, rhythmic | Stereotypic movement disorder / seizures / chorea | Tics are suppressible, suggestible, have premonitory urge, wax-and-wane |
| Sudden vocal/motor + autism | Stereotypies | Stereotypies are rhythmic, soothing, lack premonitory urge |
High-yield: Distinguish tics (suppressible, premonitory urge, wax-and-wane, can persist in sleep) from chorea (random, flowing, not suppressible) and stereotypies (rhythmic, fixed, self-soothing, seen in autism).
6. Complications
- Enuresis: low self-esteem, social withdrawal, avoidance of sleepovers/camps, family stress, punishment-related abuse risk; desmopressin overuse → hyponatraemia/seizures; imipramine overdose → cardiac arrhythmia.
- Encopresis: chronic megarectum, recurrent UTIs (girls), peer ridicule and social isolation, secondary depression/anxiety.
- Tourette: psychosocial impairment, bullying, depression, self-injurious tics; major impairment usually from comorbid ADHD/OCD; antipsychotic side effects (EPS, weight gain, metabolic, QT).
7. Recently asked / exam angle
- Mechanism of imipramine in enuresis — anticholinergic effect increasing bladder capacity + effect on sleep arousal (± weak ADH-like action). Very frequently asked.
- Drug of choice / first-line for nocturnal enuresis — alarm therapy (best long-term cure) vs desmopressin (pharmacological DOC). Read the stem: "best long-term cure" = alarm; "rapid/short-term/sleepover" = desmopressin.
- Diagnostic age cut-offs — enuresis 5 years, encopresis 4 years. (Single best fact questions.)
- Tourette diagnostic criteria — "multiple motor + ≥1 vocal tic for >1 year, onset <18 years." Coprolalia NOT required.
- Drug for Tourette — haloperidol (classic) / risperidone / aripiprazole; clonidine if ADHD coexists.
- Encopresis subtype — retentive (overflow) most common; Hirschsprung as the must-exclude differential (rectal biopsy).
- Desmopressin adverse effect — hyponatraemia/water intoxication; advise evening fluid restriction.
- Identify the tic feature — premonitory urge / suppressibility distinguishing tic from other movement disorders.
8. Rapid revision
- Enuresis age cut-off = 5 years; frequency ≥2×/week × 3 months.
- Encopresis age cut-off = 4 years; frequency ≥1/month × 3 months.
- Primary nocturnal enuresis is most common → delayed maturation + family history.
- Enuresis alarm = best long-term cure; desmopressin = pharmacological drug of choice.
- Imipramine works via anticholinergic action (↑ bladder capacity) + sleep arousal effect; danger = cardiotoxic overdose.
- Desmopressin = synthetic ADH → risk of hyponatraemia; restrict evening fluids.
- Most encopresis is retentive/overflow type secondary to constipation; "diarrhoea" is overflow leak.
- Encopresis management order: disimpaction → maintenance laxatives (PEG) → behavioural toilet training.
- Must-exclude differential for encopresis = Hirschsprung disease (rectal biopsy, absent ganglion cells, absent RAIR).
- Tourette = multiple motor + ≥1 vocal tic, >1 year, onset <18 yr; coprolalia NOT required (only ~10–15%).
- Tourette drug of choice = haloperidol/risperidone/aripiprazole; use clonidine/guanfacine if ADHD coexists.
- Tics are suppressible, have a premonitory urge, wax and wane, worsen with stress, and may persist in sleep — key to separating from chorea/stereotypies; major comorbidities = ADHD and OCD.